Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

3 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q4 2023.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 379K shares of 266M outstanding shares and own 0.14% of the company stock.
Largest 10 shareholders include Syncona Portfolio Ltd (21.3M shares), Blackstone Inc. (20.5M shares), Paradigm Biocapital Advisors LP (12.6M shares), Deep Track Capital, LP (11.9M shares), TFG Asset Management GP Ltd (8M shares), Cormorant Asset Management, LP (5.45M shares), ARMISTICE CAPITAL, LLC (3.85M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.83M shares), Frazier Life Sciences Management, L.P. (3.75M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (3M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.